Quality of care for secondary cardiovascular disease prevention in 2009–2017: population-wide cohort study of antiplatelet therapy use in Scotland

BACKGROUND: Antiplatelet therapy (APT) can substantially reduce the risk of further vascular events in individuals with established atherosclerotic cardiovascular disease (ASCVD). However, knowledge regarding the extent and determinants of APT use is limited. OBJECTIVES: Estimate the extent and iden...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:BMJ Qual Saf
Glavni autori: Thalmann, Inna, Preiss, David, Schlackow, Iryna, Gray, Alastair, Mihaylova, Borislava
Format: Artigo
Jezik:Inglês
Izdano: BMJ Publishing Group 2023
Teme:
Original Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7616486/
https://ncbi.nlm.nih.gov/pubmed/37775268
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjqs-2023-016520
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items